Table 1.
Spectral properties for 7-hydroxycoumarin derivatives
| Compound | Amount (μM) | Spectral Properties
|
||
|---|---|---|---|---|
| Absorbancea | Fluorescenceb | Fluorescence | ||
| Absorbance | ||||
| 7-hydroxycoumarin | 50 | 1.48×103 | 1.24×106 | 837 |
| 7-ethoxycoumarin | 50 | 1.30×103 | 9.60×104 | 73.8 |
|
| ||||
| R-7-hydroxywarfarin | 10 | 5.64×104 | 4.75×106 | 84.2 |
| metabolite 1d | *c | 3.78×103 | 9.68×104 | 25.6 |
| metabolite 2e | *c | 1.37×105 | 3.69×105 | 2.70 |
|
| ||||
| S-7-hydroxywarfarin | 10 | 5.29×104 | 4.48×106 | 84.7 |
| metabolite 1d | *c | 2.45×103 | 4.83×104 | 19.7 |
| metabolite 2e | *c | 7.89×104 | 2.25×105 | 2.84 |
Area of absorbance peak measured at 370 nm and 325 nm for coumarin and hydroxywarfarin derivatives respectively
Area of fluorescence emission peak measured following excitation at 370 nm and 325 nm for coumarin and hydroxywarfarin derivatives respectively
Product areas observed for the reaction containing 500 μM substrate.
Later identified as 7-HOWAR-4-GLUC (see Discussion).
Later identified as 7-HOWAR-7-GLUC (see Discussion).